NCT07926334
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07926334
Title A Study of BI 4015092, Alone or in Combination With Other Cancer Treatment, in Patients With Advanced Cancer That Has a KRAS G12D Mutation
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | AUS

Facility Status City State Zip Country Details
Yale Cancer Center New Haven Connecticut 06511 United States Details
Sarah Cannon Research Institute at Mary Crowley Dallas Texas 75230 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Chris Obrien Lifehouse Camperdown New South Wales 2050 Australia Details
Cancer Research South Australia Adelaide South Australia 5000 Australia Details
Kansai Medical University Hospital Osaka, Hirakata 573-1191 Japan Details
Japanese Foundation for Cancer Research Tokyo, Koto-ku 135-8550 Japan Details
Seoul National University Hospital Seoul 03080 South Korea Details
Samsung Medical Center Seoul 06351 South Korea Details
Hospital Universitari Vall d'Hebron Barcelona 08035 Spain Details
Hospital Clinico De Valencia (INCLIVA) Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field